Fulvestrant

NDC 68001-626 · BluePoint Laboratories.

Generic nameFulvestrant

Dosage formINJECTION

RouteINTRAMUSCULAR

Active ingredient(s)FULVESTRANT

Strength50 mg/mL

Pharmacologic classEstrogen Receptor Antagonist [EPC], Estrogen Receptor Antagonists [MoA], Selective Estrogen Receptor Modulators [MoA]

Marketing categoryANDA

Packages

68001-626-85 — 2 SYRINGE in 1 CARTON (68001-626-85) / 5 mL in 1 SYRINGE (68001-626-86)

Billed under HCPCS

J9395 — Injection, fulvestrant, 25 mg Medicare Part B payment limit (ASP + 6%): $5.02

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

0781-9055 — Fulvestrant, 16714-070 — fulvestrant, 16729-436 — Fulvestrant, 25021-471 — fulvestrant, 43598-262 — Fulvestrant, 55150-394 — Fulvestrant, 62332-650 — Fulvestrant, 63323-715 — Fulvestrant, 68001-484 — Fulvestrant, 68001-522 — Fulvestrant, 68462-317 — Fulvestrant, 70121-1463 — Fulvestrant, 70700-284 — fulvestrant, 70710-1688 — fulvestrant, 70771-1626 — fulvestrant, 70860-211 — fulvestrant, 71288-555 — Fulvestrant, 71731-6121 — fulvestrant, 83634-203 — fulvestrant, 83831-159 — fulvestrant, +3 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q4 (October 2026 release). All data sources · How to read the labels

Current data releases:ICD-10-CM FY2027 · ICD-10-PCS FY2027 · HCPCS October 2026 · MS-DRG v44 · Medicare Code Editor v44.0 · NCCI PTP Q4 2026 · MUE Q4 2026 · NCD code lists 2026-01 · LCD export September 28, 2026 · All releases and sources